MedTrace Logo

Functionality Assessments in Patients (Adults and Children) Following Treatment With Debrase Compared to Standard of Care

NCT01800981 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2013-02-28

No results posted yet for this study

Summary

Once the victim survived the acute phase, the outcome of wound healing, the scarring, became a major medical issue with complications that may lead to cosmetic and functional sequelae. Scar tissue is clinically distinguished from normal skin by an aberrant color, rough surface texture, increased thickness (hypertrophy), contraction, firmness and sometimes, decrease function.

Thus, functional and cosmetic outcomes became at least important as wound closure in assessing wound healing products

Conditions

  • Burns, Upper Extremity
  • Burns, Lower Extremity

Sponsors & Collaborators

  • MediWound Ltd

    lead INDUSTRY

Principal Investigators

  • Jan Koller, PhD · Department Head of Burs and Reconstructive Surgery

Eligibility

Min Age
10 Years
Max Age
61 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-07-31

Countries

  • Slovakia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01800981 on ClinicalTrials.gov